Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancerYoshikazu Johmura, Makoto Nakanishi, Kiyoshi Yamaguchi et al.|Journal of Clinical Investigation|2018Cited by 78
Ribosomal S6 kinase (RSK) plays a critical role in DNA damage response via the phosphorylation of histone lysine demethylase KDM4BWenwen Wu, Tomohiko Ohta, Jing Zhu et al.|Breast Cancer Research|2024Cited by 5
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinomaSaki Nakagawa, Takanori Ishida, Minoru Miyashita et al.|Breast Cancer Research and Treatment|2024Cited by 2